FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2574061671> ?p ?o ?g. }

• W2574061671 endingPage "153601211668594" @default.
• W2574061671 startingPage "153601211668594" @default.
• W2574061671 abstract "We investigated 2-(5-fluoro-pentyl)-2-methyl-malonic acid (18F-ML-10) positron emission tomography (PET) imaging of apoptosis posttherapy to determine optimal timing for predicting chemotherapy response in a mouse head/neck xenograft cancer model.BALB/c nude mice (4-8 weeks old) were implanted with UM-SCC-22B tumors. The treatment group received 2 doses of doxorubicin (10 mg/kg, days 0, 2). Small animal 18F-ML-10 PET/computed tomography was performed before and on days 1, 3, and 7 postchemotherapy. Using regions of interest around tumors, 18F-ML-10 uptake change was measured as %ID/g and uptake relative to liver. Terminal Uridine Nick-End Labeling (TUNEL) immunohistochemistry assay was performed using tumor samples of baseline and on days 1, 3, and 7 posttreatment.Treated mice demonstrated increased 18F-ML-10 uptake compared to baseline and controls, and 10 of 13 mice showed tumor volume decreases. All control mice showed tumor volume increases. Tumor-to-liver (T/L) ratios from the control group mice did not show significant change from baseline ( P > .05); however, T/L ratios of the treatment group showed significant 18F-ML-10 uptake differences from baseline compared to days 3 and 7 posttreatment ( P < .05), but no significant difference at 1 day posttreatment.2-(5-Fluoro-pentyl)-2-methyl-malonic acid PET imaging has the potential for early assessment of treatment-induced apoptosis. Timing and image analysis strategies may require optimization, depending on the type of tumor and cancer treatment." @default.
• W2574061671 created "2017-01-26" @default.
• W2574061671 creator A5000928557 @default.
• W2574061671 creator A5001429263 @default.
• W2574061671 creator A5002367405 @default.
• W2574061671 creator A5010599651 @default.
• W2574061671 creator A5011292361 @default.
• W2574061671 creator A5038339628 @default.
• W2574061671 creator A5068843099 @default.
• W2574061671 creator A5086132510 @default.
• W2574061671 creator A5086522695 @default.
• W2574061671 date "2017-01-01" @default.
• W2574061671 modified "2023-10-10" @default.
• W2574061671 title "Preclinical Evaluation of¹⁸F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors" @default.
• W2574061671 cites W125106425 @default.
• W2574061671 cites W1512072225 @default.
• W2574061671 cites W1785852384 @default.
• W2574061671 cites W1969688327 @default.
• W2574061671 cites W1970448112 @default.
• W2574061671 cites W1971967721 @default.
• W2574061671 cites W1973414672 @default.
• W2574061671 cites W1974483936 @default.
• W2574061671 cites W1984929588 @default.
• W2574061671 cites W1994274958 @default.
• W2574061671 cites W1996905391 @default.
• W2574061671 cites W1998777962 @default.
• W2574061671 cites W2001027880 @default.
• W2574061671 cites W2024669374 @default.
• W2574061671 cites W2031238012 @default.
• W2574061671 cites W2034567133 @default.
• W2574061671 cites W2045978324 @default.
• W2574061671 cites W2047922087 @default.
• W2574061671 cites W2052853635 @default.
• W2574061671 cites W2058184154 @default.
• W2574061671 cites W2067304900 @default.
• W2574061671 cites W2074478494 @default.
• W2574061671 cites W2078532650 @default.
• W2574061671 cites W2084133562 @default.
• W2574061671 cites W2085574707 @default.
• W2574061671 cites W2106730138 @default.
• W2574061671 cites W2148717903 @default.
• W2574061671 cites W2150116959 @default.
• W2574061671 cites W2161748675 @default.
• W2574061671 cites W2171071094 @default.
• W2574061671 cites W2333581391 @default.
• W2574061671 cites W2340757475 @default.
• W2574061671 cites W2351423672 @default.
• W2574061671 cites W2407015682 @default.
• W2574061671 cites W3103979403 @default.
• W2574061671 cites W4240479615 @default.
• W2574061671 doi "https://doi.org/10.1177/1536012116685941" @default.
• W2574061671 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5469516" @default.
• W2574061671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28654376" @default.
• W2574061671 hasPublicationYear "2017" @default.
• W2574061671 type Work @default.
• W2574061671 sameAs 2574061671 @default.
• W2574061671 citedByCount "14" @default.
• W2574061671 countsByYear W25740616712018 @default.
• W2574061671 countsByYear W25740616712019 @default.
• W2574061671 countsByYear W25740616712020 @default.
• W2574061671 countsByYear W25740616712021 @default.
• W2574061671 countsByYear W25740616712022 @default.
• W2574061671 countsByYear W25740616712023 @default.
• W2574061671 crossrefType "journal-article" @default.
• W2574061671 hasAuthorship W2574061671A5000928557 @default.
• W2574061671 hasAuthorship W2574061671A5001429263 @default.
• W2574061671 hasAuthorship W2574061671A5002367405 @default.
• W2574061671 hasAuthorship W2574061671A5010599651 @default.
• W2574061671 hasAuthorship W2574061671A5011292361 @default.
• W2574061671 hasAuthorship W2574061671A5038339628 @default.
• W2574061671 hasAuthorship W2574061671A5068843099 @default.
• W2574061671 hasAuthorship W2574061671A5086132510 @default.
• W2574061671 hasAuthorship W2574061671A5086522695 @default.
• W2574061671 hasBestOaLocation W25740616711 @default.
• W2574061671 hasConcept C121608353 @default.
• W2574061671 hasConcept C126322002 @default.
• W2574061671 hasConcept C142724271 @default.
• W2574061671 hasConcept C185592680 @default.
• W2574061671 hasConcept C190283241 @default.
• W2574061671 hasConcept C196795494 @default.
• W2574061671 hasConcept C204232928 @default.
• W2574061671 hasConcept C2775842073 @default.
• W2574061671 hasConcept C2776694085 @default.
• W2574061671 hasConcept C2989005 @default.
• W2574061671 hasConcept C55493867 @default.
• W2574061671 hasConcept C71924100 @default.
• W2574061671 hasConceptScore W2574061671C121608353 @default.
• W2574061671 hasConceptScore W2574061671C126322002 @default.
• W2574061671 hasConceptScore W2574061671C142724271 @default.
• W2574061671 hasConceptScore W2574061671C185592680 @default.
• W2574061671 hasConceptScore W2574061671C190283241 @default.
• W2574061671 hasConceptScore W2574061671C196795494 @default.
• W2574061671 hasConceptScore W2574061671C204232928 @default.
• W2574061671 hasConceptScore W2574061671C2775842073 @default.
• W2574061671 hasConceptScore W2574061671C2776694085 @default.
• W2574061671 hasConceptScore W2574061671C2989005 @default.
• W2574061671 hasConceptScore W2574061671C55493867 @default.
• W2574061671 hasConceptScore W2574061671C71924100 @default.

• next